[
 {
  "trial": "T01",
  "decisions": [
   {
    "id": "T01-d1",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "whole",
     "subgroup": "Niger",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.82,
      "lower": 0.75,
      "upper": 0.9,
      "level": 0.95
     },
     "treated": {
      "deaths": 1566,
      "person_years": null,
      "children": 40345,
      "rate_per_1000_person_years": 22.32,
      "rate_lower": 20.86,
      "rate_upper": 23.87
     },
     "control": {
      "deaths": 1735,
      "person_years": null,
      "children": 35747,
      "rate_per_1000_person_years": 27.26,
      "rate_lower": 25.5,
      "rate_upper": 29.13
     },
     "adjusted_for_clustering": true,
     "primary": false,
     "where": "pmid:31981558 Table 3, 'Total' row (only deaths whose cause the verbal autopsy ascertained; negative binomial regression of community-level death counts); children from the Results text (enrolled at baseline), the same numbers NCT02047981 posts as the participants of its Niger verbal-autopsy outcome",
     "note": "Counts only deaths whose cause the verbal autopsy ascertained: 1566 of the 1727 census deaths in the azithromycin group and 1735 of the 1888 in the placebo group (Table 2, Results text). Children are those enrolled at baseline."
    },
    "reason": "Table 3's Total row matches both coders (1566 vs 1735 deaths; 22.32 (20.86-23.87) vs 27.26 (25.50-29.13) per 1000 person-years; IRR 0.82 (0.75-0.90)). The same report prints each arm's children ('At baseline, 40 345 children were enrolled in the azithromycin group and 35 747 children in the placebo group'), and the registry lists 40345 and 35747 as the participants of this Niger verbal-autopsy outcome, so children are copied as printed (coder 2)."
   },
   {
    "id": "T01-d2",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "whole",
     "subgroup": "Tanzania",
     "estimate": null,
     "treated": {
      "deaths": 190,
      "person_years": 32514,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 200,
      "person_years": 33638,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:34559801 Results text",
     "note": "Rates printed per 100 person-years, not per 1000: 0.58 (azithromycin) and 0.59 (placebo) deaths/100 person-years over the course of the study. No ratio is printed; the text says only that a difference by treatment assignment was not significant after adjusting for community clustering."
    },
    "reason": "Deaths (190, 200) and person-years (32,514, 33,638) match the Results text. The rates are printed per 100 person-years (0.58, 0.59), not in the field's units, so the per-1000 fields are null and the printed rates go in the note (coder 2's handling; coder 1 put text in a numeric field)."
   },
   {
    "id": "T01-d3",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-5 months",
     "period": "whole",
     "subgroup": "Tanzania",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.8,
      "lower": 0.46,
      "upper": 1.39,
      "level": 0.95
     },
     "treated": {
      "deaths": 25,
      "person_years": 2190.1,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 32,
      "person_years": 2230.5,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": true,
     "primary": false,
     "where": "pmid:34559801 Table 1 (age-group specific negative binomial regression models at the community level)",
     "note": "Table 1 prints incidence rates per 100 person-years, not per 1000: 1.14 (azithromycin) and 1.43 (placebo)."
    },
    "reason": "Table 1's 1-5 months row matches both coders on deaths, person-years, and the IRR. Its rates are printed per 100 person-years (1.14, 1.43), not in the field's units, so the per-1000 fields are null and the printed rates go in the note (coder 2's handling; coder 1 put text in a numeric field)."
   },
   {
    "id": "T01-d4",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "6-11 months",
     "period": "whole",
     "subgroup": "Tanzania",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.92,
      "lower": 0.57,
      "upper": 1.48,
      "level": 0.95
     },
     "treated": {
      "deaths": 42,
      "person_years": 3599.2,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 45,
      "person_years": 3597.1,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": true,
     "primary": false,
     "where": "pmid:34559801 Table 1 (age-group specific negative binomial regression models at the community level)",
     "note": "Table 1 prints incidence rates per 100 person-years, not per 1000: 1.17 (azithromycin) and 1.25 (placebo)."
    },
    "reason": "Table 1's 6-11 months row matches both coders on deaths, person-years, and the IRR. Its rates are printed per 100 person-years (1.17, 1.25), not in the field's units, so the per-1000 fields are null and the printed rates go in the note (coder 2's handling; coder 1 put text in a numeric field)."
   },
   {
    "id": "T01-d5",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "12-23 months",
     "period": "whole",
     "subgroup": "Tanzania",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 1.03,
      "lower": 0.72,
      "upper": 1.48,
      "level": 0.95
     },
     "treated": {
      "deaths": 59,
      "person_years": 7564.1,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 60,
      "person_years": 7926.0,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": true,
     "primary": false,
     "where": "pmid:34559801 Table 1 (age-group specific negative binomial regression models at the community level)",
     "note": "Table 1 prints incidence rates per 100 person-years, not per 1000: 0.78 (azithromycin) and 0.76 (placebo)."
    },
    "reason": "Table 1's 12-23 months row matches both coders on deaths, person-years, and the IRR. Its rates are printed per 100 person-years (0.78, 0.76), not in the field's units, so the per-1000 fields are null and the printed rates go in the note (coder 2's handling; coder 1 put text in a numeric field)."
   },
   {
    "id": "T01-d6",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "24-59 months",
     "period": "whole",
     "subgroup": "Tanzania",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 1.05,
      "lower": 0.74,
      "upper": 1.5,
      "level": 0.95
     },
     "treated": {
      "deaths": 64,
      "person_years": 19165.5,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 63,
      "person_years": 19888.5,
      "children": null,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": true,
     "primary": false,
     "where": "pmid:34559801 Table 1 (age-group specific negative binomial regression models at the community level)",
     "note": "Table 1 prints incidence rates per 100 person-years, not per 1000: 0.33 (azithromycin) and 0.32 (placebo)."
    },
    "reason": "Table 1's 24-59 months row matches both coders on deaths, person-years, and the IRR. Its rates are printed per 100 person-years (0.33, 0.32), not in the field's units, so the per-1000 fields are null and the printed rates go in the note (coder 2's handling; coder 1 put text in a numeric field)."
   },
   {
    "id": "T01-d7",
    "decided": null,
    "reason": "Same registry adverse-events entry as T01-d8 (3262 of 97047 vs 3392 of 93191). The module prints no time frame, so 'whole' is not supported; T01-d8 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T01-d8",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-60 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": null,
     "treated": {
      "deaths": 3262,
      "person_years": null,
      "children": 97047,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 3392,
      "person_years": null,
      "children": 93191,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "NCT02047981 posted results, adverse events module, all-cause deaths by group (ages from the group descriptions: children aged 1 month to 60 months)",
     "note": "The adverse events module prints deaths by group with no time frame. Its denominators (97047, 93191) are the participants of the registry's 24-month primary outcome; the group descriptions add that in Niger during year 3 all communities were offered azithromycin."
    },
    "reason": "The module prints 'deaths 3262 of 97047' (azithromycin) and 'deaths 3392 of 93191' (placebo) with no time frame, so the period is 'not printed'. Kept in place of T01-d7, the same entry labelled 'whole'."
   }
  ]
 },
 {
  "trial": "T02",
  "decisions": [
   {
    "id": "T02-d1",
    "decided": null,
    "reason": "Same registry adverse-events entry as T02-d2 (1493 of 33173 vs 1584 of 33055). The module prints no time frame, so 'whole' is not supported; T02-d2 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T02-d2",
    "decided": {
     "comparison": "Azithro vs Placebo",
     "ages": "1-60 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": null,
     "treated": {
      "deaths": 1493,
      "person_years": null,
      "children": 33173,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 1584,
      "person_years": null,
      "children": 33055,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "NCT03338244 posted results, adverse events module, all-cause deaths by group (ages from the group descriptions: children aged 1 month to 60 months)",
     "note": "The adverse events module prints deaths by group with no time frame. Its denominators (33173, 33055) are the participants of the registry's 24-month primary outcome."
    },
    "reason": "The module prints 'deaths 1493 of 33173' (Azithro) and 'deaths 1584 of 33055' (Placebo) with no time frame, so the period is 'not printed'. Kept in place of T02-d1, the same entry labelled 'whole'."
   }
  ]
 },
 {
  "trial": "T03",
  "decisions": [
   {
    "id": "T03-d1",
    "decided": null,
    "reason": "Same registry adverse-events entry for Azithro 1-59 vs Placebo as T03-d4 (1914 of 153626 vs 1923 of 124617). The module prints no time frame, so 'whole' is not supported; T03-d4 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T03-d2",
    "decided": null,
    "reason": "Same registry adverse-events entry for Azithro 1-11 vs Placebo as T03-d5 (1666 of 104374 vs 1923 of 124617). The module prints no time frame, so 'whole' is not supported; T03-d5 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T03-d3",
    "decided": null,
    "reason": "Same registry adverse-events entry for Azithro 1-59 vs Azithro 1-11 as T03-d6 (1914 of 153626 vs 1666 of 104374). The module prints no time frame, so 'whole' is not supported; T03-d6 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T03-d4",
    "decided": {
     "comparison": "Azithro 1-59 vs Placebo",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": null,
     "treated": {
      "deaths": 1914,
      "person_years": null,
      "children": 153626,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 1923,
      "person_years": null,
      "children": 124617,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "NCT04224987 posted results, adverse events module, all-cause deaths by group (ages from the group descriptions: children 1-59 months)",
     "note": "The adverse events module prints deaths by group with no time frame. Its denominators (Azithro 1-11 104374, Azithro 1-59 153626, Placebo 124617) are the participants of the registry's primary outcome for children 1-59 months."
    },
    "reason": "For Azithro 1-59 vs Placebo the module prints 1914 of 153626 and 1923 of 124617 deaths with no time frame, so the period is 'not printed'. Kept in place of T03-d1, the same entry labelled 'whole'."
   },
   {
    "id": "T03-d5",
    "decided": {
     "comparison": "Azithro 1-11 vs Placebo",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": null,
     "treated": {
      "deaths": 1666,
      "person_years": null,
      "children": 104374,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 1923,
      "person_years": null,
      "children": 124617,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "NCT04224987 posted results, adverse events module, all-cause deaths by group (ages from the group descriptions: children 1-59 months)",
     "note": "The adverse events module prints deaths by group with no time frame. Its denominators (Azithro 1-11 104374, Azithro 1-59 153626, Placebo 124617) are the participants of the registry's primary outcome for children 1-59 months."
    },
    "reason": "For Azithro 1-11 vs Placebo the module prints 1666 of 104374 and 1923 of 124617 deaths with no time frame, so the period is 'not printed'. Kept in place of T03-d2, the same entry labelled 'whole'."
   },
   {
    "id": "T03-d6",
    "decided": {
     "comparison": "Azithro 1-59 vs Azithro 1-11",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": null,
     "treated": {
      "deaths": 1914,
      "person_years": null,
      "children": 153626,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 1666,
      "person_years": null,
      "children": 104374,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "NCT04224987 posted results, adverse events module, all-cause deaths by group (ages from the group descriptions: children 1-59 months)",
     "note": "The adverse events module prints deaths by group with no time frame. Its denominators (Azithro 1-11 104374, Azithro 1-59 153626, Placebo 124617) are the participants of the registry's primary outcome for children 1-59 months."
    },
    "reason": "For Azithro 1-59 vs Azithro 1-11 the module prints 1914 of 153626 and 1666 of 104374 deaths with no time frame, so the period is 'not printed'. Kept in place of T03-d3, the same entry labelled 'whole'."
   }
  ]
 },
 {
  "trial": "T04",
  "decisions": [
   {
    "id": "T04-d1",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "whole",
     "subgroup": null,
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.82,
      "lower": 0.66,
      "upper": 1.01,
      "level": 0.95
     },
     "treated": {
      "deaths": null,
      "person_years": null,
      "children": 34399,
      "rate_per_1000_person_years": 8.2,
      "rate_lower": 7.1,
      "rate_upper": 9.4
     },
     "control": {
      "deaths": null,
      "person_years": null,
      "children": 33847,
      "rate_per_1000_person_years": 10.0,
      "rate_lower": 8.4,
      "rate_upper": 11.7
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:41021553 Table 2 'Overall (Jan-Dec)' (rates, IRR) and Table 1 'Number of Children'; same numbers in pmid:40343013 Tables 1 and 2",
     "note": "Children are Table 1's 'Number of Children' for the 146 azithromycin and 139 placebo communities analysed; NCT03676764 states its primary analysis included 34399 and 33847 children. The main report (pmid:38349371) prints the overall IRR as 0.82 (95% CI 0.67-1.02)."
    },
    "reason": "Table 2's 'Overall (Jan-Dec)' column matches both coders (8.2 (7.1 to 9.4) vs 10.0 (8.4 to 11.7); IRR 0.82 (0.66 to 1.01)). The same report's Table 1 prints each arm's 'Number of Children' (34,399; 33,847) for the communities analysed, and the registry gives the same numbers as the children in the primary analysis, so children are copied as printed (coder 1)."
   },
   {
    "id": "T04-d2",
    "decided": null,
    "reason": "Same Table 4 'Across all clusters (N=285)' estimate as T04-d7. Table 4 prints no period, and its rates (9.0 vs 11.5) are not Table 2's whole-follow-up 'Overall (Jan-Dec)' rates (8.2 vs 10.0), so 'whole' is not supported; T04-d7 is kept with period 'not printed' and this one dropped."
   },
   {
    "id": "T04-d3",
    "decided": null,
    "reason": "Same Table 4 'Coverage below 80% (N=222)' estimate as T04-d5. Table 4 prints no period, so 'whole' is not supported, and 'months covered not stated' belongs to the period, not the subgroup; T04-d5 is kept and this one dropped."
   },
   {
    "id": "T04-d4",
    "decided": null,
    "reason": "Same Table 4 'Coverage 80% or above (N=86)' estimate as T04-d6. Table 4 prints no period, so 'whole' is not supported, and 'months covered not stated' belongs to the period, not the subgroup; T04-d6 is kept and this one dropped."
   },
   {
    "id": "T04-d5",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": "clusters with SMC coverage below 80% (N=222)",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.73,
      "lower": 0.56,
      "upper": 0.96,
      "level": 0.95
     },
     "treated": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 8.9,
      "rate_lower": 7.3,
      "rate_upper": 10.5
     },
     "control": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 12.1,
      "rate_lower": 9.6,
      "rate_upper": 14.7
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:40343013 Table 4 'Coverage below 80% (N=222)' and Results text; the IRR is also in pmid:41021553 Results text (its S1 and S2 Tables are not in the sources)",
     "note": "Table 4 prints no period. The note to Figure 5 (rates by SMC coverage level, the analysis in Table 3) says that analysis was restricted to months during and after SMC distribution (July-December). Table 4's note: some clusters may appear in both high and low coverage counts if their estimates were above the threshold in one year and below the threshold in another year."
    },
    "reason": "Table 4 and both SMC reports' Results text print AZ 8.9 (7.3 to 10.5), placebo 12.1 (9.6 to 14.7), IRR 0.73 (0.56 to 0.96) for clusters with SMC coverage below 80%. No period is printed for Table 4, so the period is 'not printed' (coder 2's 'not stated'); subgroup as printed. Kept in place of T04-d3."
   },
   {
    "id": "T04-d6",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": "clusters with SMC coverage of 80% or above (N=86)",
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 1.0,
      "lower": 0.59,
      "upper": 1.69,
      "level": 0.95
     },
     "treated": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 9.2,
      "rate_lower": 5.9,
      "rate_upper": 12.6
     },
     "control": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 9.2,
      "rate_lower": 5.8,
      "rate_upper": 12.7
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:40343013 Table 4 'Coverage 80% or above (N=86)' and Results text; the IRR is also in pmid:41021553 Results text (its S1 and S2 Tables are not in the sources)",
     "note": "Table 4 prints no period. The note to Figure 5 (rates by SMC coverage level, the analysis in Table 3) says that analysis was restricted to months during and after SMC distribution (July-December). Table 4's note: some clusters may appear in both high and low coverage counts if their estimates were above the threshold in one year and below the threshold in another year."
    },
    "reason": "Table 4 and both SMC reports' Results text print AZ 9.2 (5.9 to 12.6), placebo 9.2 (5.8 to 12.7), IRR 1.0 (0.59 to 1.69) for clusters with SMC coverage of 80% or above. No period is printed for Table 4, so the period is 'not printed' (coder 2's 'not stated'); subgroup as printed. Kept in place of T04-d4."
   },
   {
    "id": "T04-d7",
    "decided": {
     "comparison": "Biannual mass oral azithromycin vs Biannual mass oral placebo",
     "ages": "1-59 months",
     "period": "not printed",
     "subgroup": null,
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 0.78,
      "lower": 0.61,
      "upper": 0.99,
      "level": 0.95
     },
     "treated": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 9.0,
      "rate_lower": 7.5,
      "rate_upper": 10.4
     },
     "control": {
      "deaths": null,
      "person_years": null,
      "children": null,
      "rate_per_1000_person_years": 11.5,
      "rate_lower": 9.4,
      "rate_upper": 13.6
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:40343013 Table 4 'Across all clusters (N=285)'",
     "note": "Table 4 prints no period. The note to Figure 5 (rates by SMC coverage level, the analysis in Table 3) says that analysis was restricted to months during and after SMC distribution (July-December). Table 4's 'Across all clusters' rates (9.0 and 11.5 per 1000 person-years) differ from Table 2's 'Overall (Jan-Dec)' rates (8.2 and 10.0)."
    },
    "reason": "Table 4 prints AZ 9.0 (7.5 to 10.4), placebo 11.5 (9.4 to 13.6), IRR 0.78 (0.61 to 0.99) across all 285 clusters. All clusters is everyone in the age band, so subgroup is null per the codebook (the column is named in where); no period is printed, so 'not printed'. Kept in place of T04-d2."
   }
  ]
 },
 {
  "trial": "T08",
  "decisions": [
   {
    "id": "T08-d1",
    "decided": {
     "comparison": "Biannual mass oral azithromycin + child health days vs Biannual mass placebo + child health days",
     "ages": "1-11 months",
     "period": "whole",
     "subgroup": null,
     "estimate": {
      "measure": "incidence rate ratio",
      "value": 1.05,
      "lower": 0.77,
      "upper": 1.45,
      "level": 0.95
     },
     "treated": {
      "deaths": 496,
      "person_years": null,
      "children": 193248,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "control": {
      "deaths": 247,
      "person_years": null,
      "children": 97205,
      "rate_per_1000_person_years": null,
      "rate_lower": null,
      "rate_upper": null
     },
     "adjusted_for_clustering": null,
     "primary": false,
     "where": "pmid:41506755 Results text, secondary analysis of cumulative probabilities of mortality with a synthetic cohort (online supplemental table 4 is not in the sources)",
     "note": "Mortality printed per 1000 live births, not per 1000 person-years: 3.3 (95% CI 2.7 to 3.9) in azithromycin communities and 3.1 (95% CI 2.3 to 3.9) in placebo communities. Children are live births in the synthetic cohort."
    },
    "reason": "Deaths (496, 247), live births (193 248, 97 205), and the IRR 1.05 (0.77 to 1.45) match the Results text. Mortality is printed per 1000 live births, not per 1000 person-years, so the rate fields are null and the printed values go in the note (coder 2's handling; coder 1 put text in numeric fields)."
   }
  ]
 }
]